Genese K. Dopson: Lawyer with Wilson Elser Moskowitz Edelman & Dicker LLP

Genese K. Dopson


Peer Rating
Rating Not Shown

Client Rating

Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials Ratings & Reviews

Practice Areas

  • e-Discovery
  • Employment & Labor
  • Insurance & Reinsurance Coverage
  • Pharmaceuticals & Medical Devices
  • Product Liability
  • Employee Benefits
Contact InfoTelephone: 415.625.9360
Fax: 415.434.1370
University El Camino College, A.A.R.N., 1972; Mount St. Mary's College, B.S., 1979
Law SchoolLoyola Law School, J.D., 1982
Admitted1983, California and U.S. District Court, Central and Northern Districts of California; 1984, U.S. Court of Appeals, Ninth Circuit

Memberships & Affiliations

California State Bar Association
Claims & Litigation Management Alliance (CLM)


Genese Dopson focuses her practice on the defense of companies in employment matters and in the defense of pharmaceutical and medical device manufacturers, as well as the defense of personal injury, insurance bad faith, employment and discrimination matters. She has successfully managed the defense of multi-plaintiff, multi-state litigation and has served as national coordinating counsel in pharmaceutical and medical device mass tort litigation. She is a former member of the editorial advisory board of MX Magazine, a publication that served the medical device industry.

Leveraging her first career as a registered nurse, Genese brought her drug and medical device practice to Wilson Elser in 2009. She leads the firm's Pharmaceutical & Medical Device practice and coordinates efforts to field a nationwide team of creative, resolution-oriented attorneys in the drug and medical device arena. As one of twelve attorneys elevated to the firm's Senior Trial Group, she possesses keen insight into case assessment and courtroom strategies.

Genese, who holds a second degree black belt in Enshin karate, is known for her ability to defend complex cases and handle tough opposing counsel when matters become heated. Notwithstanding her ability to confront and fight, Genese prides herself on providing her clients early case assessment and a solid work product directed toward the earliest possible dispute resolution.

Areas of Focus

Product Liability
Serving as national coordinating counsel, Genese has strategically and economically designed and coordinated defense strategies for brand and generic drug manufacturers as well as medical device manufacturers. She has achieved defense verdicts in all of her products liability trials. By way of example, she obtained a defense verdict for a cautery manufacturer in Garcia v. ConMed Corporation, where the manufacturer was sued by a boy who developed an airway fire during a tonsillectomy procedure. Genese also helped write a motion for summary judgment in the case of Gaeta v. Perrigo, where the court granted preemption to the generic drug manufacturer based on ANDA. She designed the defense strategy that resulted in an early settlement for the brand drug manufacturer in the coordinated quinine litigation, months in advance of resolution by any other drug manufacturer in the mass tort quinine litigation. Genese keeps current with the latest regulations and case law affecting the pharmaceutical and medical device industries. She regularly presents to industry organizations and contributes to relevant publications.

Employment & Discrimination
Genese has defended numerous employers and served as lead trial counsel in several wrongful termination jury trials where plaintiffs alleged discrimination due to gender, obesity, age and/or medical disability. She handles cases arising under Title VII, the Age Discrimination in Employment Act, the Americans with Disabilities Act, the Family and Medical Leave Act and the Employee Retirement Income Security Act. She obtained a defense verdict in Durand v. SSA Terminals, an age discrimination and medical disability suit where the employer terminated the employee allegedly after 42 years of employment one day after the employee returned to work from a medical disability.

Insurance / Bad Faith
Insurance bad faith actions carry the potential for substantial exposure and Genese is highly experienced in handling the defense of these claims. Over her years of practice, Genese has tried several insurance bad faith cases to verdict. After six weeks of trial in 2000, she obtained a defense verdict in Snowden v. Fire Insurance Exchange, an arson bad faith case where the jury was convinced it was more probable than not that the insured committed arson and denial of insurance benefits was reasonably justified.

Awards & Distinctions

Medmarc Insurance Company's Attorney of the Year, 2005
Selected for inclusion in Northern California Super Lawyers, 2013-2015


Is Our Legal System Ready for the Evolution of 3D Printing Technology? September 9, 2015


3D-Printed Prescription Drugs a Huge Stride Forward for Personalized Medicine

3D-Printed Prescription Drugs

September 16, 2015

In addition to tailoring prescription drugs to the needs of particular classes of patients, 3D printing opens the possibility of tailoring each tablet to the needs of one specific patient, regardless of the physical location of the printer. Until now, this has not been financially feasible with mass-produced medications.

Modernizing and Coordinating the Regulatory System of Biotechnology Products

Regulatory System for Biotechnology Products

July 23, 2015

Substantial advances in biotechnology and accompanying additional regulation have led to uncertainty in agency jurisdiction and lack of predictability, creating unnecessary costs and inhibiting innovation. The Office of Science and Technology Policy aims to correct these problems with the process outlined in a July 2015 memorandum.

FDA Approves Biosimilar Agent Zarxio: Dawn of a New Era in Pharmaceutical Therapy and Product Liability Law

Biosimilars: A New Era in Product Liability Law

March 13, 2015

The FDA has approved the first biosimilar agent under abbreviated procedures outlined in the Biologics Price Competition and Innovation Act of 2009. The approval heralds a new era of less-expensive biologics, a class of therapeutic agents that are among the most expensive in the U.S. market, and foreshadows a new era in product liability law, as plaintiffs' attorneys are likely to exploit the unique statutory and regulatory status of biosimilar agents in pursuing product liability claims against manufacturers.

New Jersey Seeks to Ban the Use of “Microbeads” in Consumer Care

NJ Seeks Ban on Microbeads” in Consumer Care Products

October 30, 2014

New Jersey's Legislature has approved a bill that is expected to come before the Governor's Office in November 2014. If enacted, the bill's prohibition against the production or manufacture of personal care products containing microbeads would commence January 1, 2018. The measure prohibits the sale, offer for sale or promotion of these items on or after January 1, 2019. In addition, no person will be able to sell, offer for sale or offer for promotion over-the-counter drugs containing synthetic plastic microbeads in the state beginning January 1, 2020.

U.S. Supreme Court Rules in Favor of Generic Drug Manufacturers in Pliva, Inc. v. Mensing

June 2011

The U.S. Supreme Court has ruled that generic drug makers cannot be sued for failure to warn consumers of possible side effects if they reproduce the exact warnings in brand-name equivalent packaging. The FDA is likely to weigh in, as it does hold all manufacturers responsible for language on their packaging.


Changes to 510(k) Regulatory Process and Laboratory-developed Tests

Speaking Engagements

October 23-24, 2014

Navigators Advisory Council Meeting

The FDA's New Regulatory Scheme for Laboratory-developed Tests (LDT): Potential Regulatory and Litigation Impact

Speaking Engagements

October 16-17, 2014

Navigators Advisory Council Meeting

Medical Device Cyber Risks

Speaking Engagements

June 11, 2014

27th Annual Medmarc Insurance Group Medical Device Seminar

Liabilities Associated with Clinical Trials

Speaking Engagements



Additional Events

“Title II of the Americans With Disabilities Act: The Best Defense” San Mateo County Public Entity Seminar, 2011

“Generic Preemption: New Life for Product Liability Defense?” webinar presentation sponsored by Berkeley Life Sciences, 2011

“Electronically Stored Information: Some Thoughts for Insurers” for Medmarc Insurance Company, 2010

“Pharmacovigilance in a Post-Wyeth v. Levine World, ” webinar presentation to pharmaceutical manufacturers, 2010

“Direct and Cross-Examination of Regulatory/FDA Experts, ” American Conference Institute's FDA Boot Camp, 2010

“Innovator Pharmaceutical Companies at Risk for Products Manufactured by Generic Firms in California: Defending Product Liability Claims in the Wake of Conte v. Wyeth, ” nationally broadcast audio program for FDA News, 2009

“ANDA Preemption for Generic Drug Manufacturers, ” Medmarc Insurance Company, 2008

Moderator, BIOMEDevice Forum on Product Liability Issues, 2007

“Defending Devices: Rx for Success, ” Medmarc Annual Attorney Seminar: Panel Presentation, 2006

“Clinical Trials and Recent Liability Issues, ” Medmarc Annual Attorney Seminar, 2003

“Clinical Trials: Risky Business; Evaluating Liability, ” Medmarc Broker Seminar, San Francisco, 2002

“Liability Issues Confronting Medical Device Manufacturers, ” Medtech Seminar, San Francisco, 2002

Panel Presentation re Federal Court Judicial Vacancies, Medmarc Annual Attorney Seminar, 2001

“Trial Tactics in Defending a Brain Damage Case, ” Medmarc Annual Attorney Seminar, 1998


Wilson Elser's Genese Dopson Accepts Invitation to Join CLM

August 8, 2013

Dopson Receives Summary Judgment in a Product Liability Case Filed against Arthrex

October 2, 2012

Dopson Named Deputy Regional Managing Partner of Wilson Elser's San Francisco Office

August 7, 2012

Reported CasesRepresentative Matters: Cases Tried to Verdict Tommy Dye v. Asbestos Corporation Ltd. (October 2009); San Francisco Superior Court No. 274606: Asbestosis Andrew Garcia v. ConMed Corporation et al (December 2008); Santa Clara County Superior Court No. 104 CV 023354: Medical Products Liability Steven Durand v. SSA Terminals et al (November 2006); Alameda County Superior Court No. RGO4141330: Wrongful Term./Age/Disability Kwi Butler v. Aaron Medical Industries aka Bovie Medical Corp. (November 2004); U.S.D.C., Northern District, Case No. C 03-00896: Medical Products Liability David Snowden v. Fire Insurance Exchange (April 2000); Sonoma County Superior Court No. 213578: Insurance Bad Faith/Arson Daniel Impey v. Kevin Wesley, PeopleSoft, Inc. & Avis Rent-A-Car (January 2000); Alameda County Superior Court No. V-015749-2: Personal Injury/Auto Carol Picchi v. Ricon Corporation (July 1997); Santa Clara County Superior Court No. CV743035: Medical Products Liability John Rossi v. Northern Automotive Corp. (September 1995); Alameda County Superior Court No. 702424-1: Wrongful Term./Disability Kimberly Patterson v. Kragen Auto Parts (February 1994); Sacramento County Superior Court No. 529107: Sexual Harassment Johnson v. Transamerica Ins. Co. (October 1993); San Francisco County Superior Court No. 938063: Insurance Bad Faith Neilsen v. Safeway Stores, Inc. (April 1992); Sonoma County Superior Court No. 171059: Slip and Fall Cornelius Andrews v. Kragen Auto Parts (October 1991); San Francisco County Municipal Court No. 048289: False Arrest Heidi Barron v. Kragen Auto Parts (May 1991); Contra Costa County Superior Court No. C89-00526: Sexual Harassment Gerne v. Transamerica Ins. Co. (April 1991); San Francisco County Superior Court No. 917062: Insurance Bad Faith Kragen Auto Supply v. Kirkorian Devel. Co. (June 1990); Santa Clara County Superior Court No. 645405: Declar. Relief/Indemnity Phillips v. Keystone Family, Inc. (June 1989); San Francisco County Superior Court No. 859531: Premises/Slip and Fall Joseph Bartee v. Fibreboard Corporation (April 1988); Alameda County Superior Court No. 588498-0: Death/Mesothelioma John Vasko v. Raymark Industries (January 1988); San Francisco County Superior Court No. 814471: Asbestosis Paula Sheppard v. Larson Ins. Agency (November 1987); Shasta County Superior Court No. 27422: Insurance Broker E&O Woodward v. Seattle Standard Corporation (October 1987); Shasta County Superior Court No. 88319: Premises/Slip and Fall Murphy v. Whitcomb, M.D. (August 1986); Butte County Superior Court No. 85483: Medical Malpractice Rivera v. Redding Police Department (February 1986); Shasta County Superior Court No. 77864: Police Misconduct Socorro Chicas v. Pioneer Hospital (May 1984); Los Cerritos County Municipal Court: Medical Malpractice Collins v. Monrovia Comm. Hospital (February 1984); Santa Anita County Municipal Court: Premises/Slip and Fall

Documents by this lawyer on

Subscribe to this feed

3D-Printed Prescription Drugs a Huge Stride Forward for Personalized Medicine
Amy L. Baker,Genese K. Dopson,Rosario M. Vignali, September 17, 2015
Advances in 3D printing (3DP) technology have paved the way for pharmaceutical companies to print prescription drugs. Aprecia Pharmaceuticals recently announced that the FDA has granted it approval to manufacture Spritam® (levetiracetam), an antiepileptic medication, using 3DP technology....

Is Our Legal System Ready for the Evolution of 3D Printing Technology?
Amy L. Baker,Genese K. Dopson,Rosario M. Vignali, September 10, 2015
When we wrote back in November 2013 about 3D Printing and Product Liability Law, we predicted that the 3D printing revolution “will challenge our long-held notions of product liability law and the common assumptions made regarding the liability of various entities in the chain of...

Modernizing and Coordinating the Regulatory System of Biotechnology Products
Genese K. Dopson,Jacob R. Graham, August 5, 2015
On July 2, 2015, the U.S. Office of Science and Technology Policy (OSTP) of the Office of the President issued a memorandum to initiate a process to coordinate, update and modernize the federal regulatory system governing biotechnology products. The process outlined in the OSTP memo will impact the...

View Ratings & Reviews
Profile Visibility
#899 in weekly profile views out of 22,139 lawyers in San Francisco, California
#93,313 in weekly profile views out of 1,733,488 total lawyers Overall

Office Information

Genese K. Dopson

525 Market Street, 17th Floor
San FranciscoCA 94105-2725


Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now